Evidence map›Paper›PMID 34448987›Full record

ArticleVirus genes2021

A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020.

Broňa Brejová, Kristína Boršová, Viktória Hodorová, Viktória Čabanová, Lenka Reizigová, Evan D Paul, Pavol Čekan, Boris Klempa, Jozef Nosek, Tomáš Vinař

Open access · greenAbstract read
In one paragraph

Article in Virus genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Phylogenetic Changes in SARS-CoV-2 Virus in Bosnian-Herzegovinian Population Over the Period of Two Years.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Broňa Brejová *Faculty of Mathematics, Physics and Informatics, Comenius University in Bratislava, Mlynská dolina, 842 48, Bratislava, Slovak Republic.
Kristína Boršová *Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Dúbravská cesta 9, 845 05, Bratislava, Slovak Republic.
Viktória HodorováDepartment of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15, Bratislava, Slovak Republic.
Viktória ČabanováInstitute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Dúbravská cesta 9, 845 05, Bratislava, Slovak Republic.
Lenka ReizigováRegional Authority of Public Health, Trenčín, Slovak Republic.
Evan D PaulMultiplexDX, s.r.o., Comenius University in Bratislava Science Park, Ilkovičova 8, 841 04, Bratislava, Slovak Republic.
Pavol ČekanMultiplexDX, s.r.o., Comenius University in Bratislava Science Park, Ilkovičova 8, 841 04, Bratislava, Slovak Republic.
Boris KlempaInstitute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Dúbravská cesta 9, 845 05, Bratislava, Slovak Republic. boris.klempa@savba.sk.ORCID http://orcid.org/0000-0002-6931-1224
Jozef NosekDepartment of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15, Bratislava, Slovak Republic.
Tomáš VinařFaculty of Mathematics, Physics and Informatics, Comenius University in Bratislava, Mlynská dolina, 842 48, Bratislava, Slovak Republic.
Comenius University Bratislava · SKBiomedical Research Center of the Slovak Academy of Sciences · SKVitenparken · NOInstitute of Chemistry of the Slovak Academy of Sciences · SKUniversity of Trnava · SK

Funding

Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR VEGA 1/0458/18Agentúra na Podporu Výskumu a Vývoja APVV-18-0239Agentúra na Podporu Výskumu a Vývoja PP-COVID-20-0017Agentúra na Podporu Výskumu a Vývoja PP-COVID-20-0116Horizon 2020 872539Horizon 2020 Framework Programme 871029Slovenská Akadémia Vied VEGA 1/0463/20
6 · The paper itself

Abstract

SARS-CoV-2 mutants carrying the ∆H69/∆V70 deletion in the amino-terminal domain of the Spike protein emerged independently in at least six lineages of the virus (namely, B.1.1.7, B.1.1.298, B.1.160, B.1.177, B.1.258, B.1.375). We analyzed SARS-CoV-2 samples collected from various regions of Slovakia between November and December 2020 that were presumed to contain B.1.1.7 variant due to drop-out of the Spike gene target in an RT-qPCR test caused by this deletion. Sequencing of these samples revealed that although in some cases the samples were indeed confirmed as B.1.1.7, a substantial fraction of samples contained another ∆H69/∆V70 carrying mutant belonging to the lineage B.1.258, which has been circulating in Central Europe since August 2020, long before the import of B.1.1.7. Phylogenetic analysis shows that the early sublineage of B.1.258 acquired the N439K substitution in the receptor-binding domain (RBD) of the Spike protein and, later on, also the deletion ∆H69/∆V70 in the Spike N-terminal domain (NTD). This variant was particularly common in several European countries including the Czech Republic and Slovakia but has been quickly replaced by B.1.1.7 early in 2021.

Indexed as

PhylogenySequence DeletionCOVID-19EuropeHumansSARS-CoV-2Spike Glycoprotein, CoronavirusTime FactorsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2B.1.1.7B.1.258DeletionSARS-CoV-2SpikeVariant

Identifiers

PMID34448987
PMCPMC8390540
OpenAlexW3128573426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.